# Contact LuvThy Peptide — Editorial Desk

> Reach the LuvThy Peptide editorial desk regarding citations, corrections, or research-related correspondence about our Sexual & Reproductive Research peptide digest.

Correspondence on citations, corrections, and research-related inquiries — the things a reference desk most wants to hear.

## Editorial correspondence

LuvThy Peptide welcomes correspondence on the research record: a citation quoted inaccurately, a regulatory status that has changed, or a peer-reviewed study on PT-141 or kisspeptin that should be reflected in the [references page](/references). Corrections that improve accuracy are the most useful messages this desk receives and are read carefully.

The most actionable notes specify three things: the page in question, the exact passage, and the supporting citation — a DOI or PubMed ID wherever possible. That allows verification against the source quickly.

**Editorial mailbox:** editors@luvthypeptide.com

## What this desk cannot do

So that no message goes unanswered for the wrong reason, a few things fall outside what this site can address. LuvThy Peptide is a literature digest, not a clinic or a vendor.

- Advise on, recommend, or comment on human use of any compound described here.
- Suggest a dose, schedule, or route of administration for any individual.
- Comment on whether a research finding applies to a particular person or condition.
- Sell, source, recommend, or help locate any compound from any supplier.
- Advise athletes subject to anti-doping rules on whether or how to use these compounds.

Readers seeking medical guidance should consult a licensed clinician in their own jurisdiction. Responses to editorial correspondence are not guaranteed; the mailbox is monitored intermittently.

---

A clinician's-briefing digest of the sexual and reproductive research-peptide literature — citations sourced, never prescribed.